Clinical Excellence in Cardiovascular Prevention and Lipidology
New advances in the role of Lp(a) in atherosclerosis; Therapeutic implications
Disclosure : B.G.N has received consultancy fees or lecture honoraries from Astra Zeneca, Pfizer, Merck, Karo Bio, Abbott, Sanofi-Aventis, Regeneron, Boehringer Ingelheim, and Omthera.
45 slide(s) – 00:34:03 – English – 2012-02-10
After reviewing this presentation the participant will be able to:
-Discuss the role of lipoprotein(a) as a cardiovascular risk factor
-Describe appropriate diagnostic and treatment approaches for patients with high levels of lipoprotein(a)